Forcefield Ventures
VC Fund
Forcefield Ventures is a venture capital firm.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Forcefield Ventures invests in
Stages Forcefield Ventures invests in
Countries Forcefield Ventures invests in
Investment Focus
Industry
- Pharmaceutical 2 (67%)
- Medical 1 (33%)
- Biotechnology 1 (33%)
- Information Technology 1 (33%)
Stage
- Seed 2 (67%)
- Series A 1 (33%)
Country
- China 2 (67%)
- United States 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Amide synthesizes peptides that are difficult to obtain through existing means, bridging the gap between traditional solid phase peptide synthesis and biological expression. By using unnatural amino acids and artificial protein backbones, our team is expanding what is biologically possible. Amide’s Automated Fast Flow Peptide Synthesizer (AFPS)leverages flow to dramatically improve solid phase peptide synthesis. Using the power of flow, we can generate highly reactive intermediates in situ, maintain excellent heat and mass transfer, and achieve much better synthetic outcomes than alternative SPPS methods. With all these advantages, AFPS allows biopharma pioneers to dramatically re-think what’s possible. Let Amide broaden your horizons with better, faster synthesis. | $7.5M / Series A / Jul 28, 2023 | |
|
|
CytoCan Corp. operates as a biotechnology company that focus on the research and development of multi-specific fusion protein drugs. | $1.5M / Seed / Feb 07, 2023 | |
|
|
META Pharmaceuticals is a cutting-edge drug development company specializing in autoimmune diseases. | $15M / Seed / Jun 13, 2022 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Forcefield Ventures invest in?
Forcefield Ventures invests primarily in Pharmaceutical, Medical and Biotechnology startups, most often at Seed and Series A stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Forcefield Ventures last invest?
The most recent investment recorded for Forcefield Ventures closed in Jul 2023. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!